Stock Earnings
AGIO’s short interest shows a sharp decline on 2025-07-15
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Menu
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Agios Pharmaceuticals Inc’s recent filing unveils that its Director Scadden David unloaded Company’s shares for reported $56000.0 on Jul 10
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Agios Pharmaceuticals
Agios Pharmaceuticals Inc’s recent filing unveils that its Director Scadden David unloaded Company’s shares for reported $56000.0 on Jul 10
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Agios Pharmaceuticals
Agios Pharmaceuticals Inc’s recently made public that its Chief Medical Officer Gheuens Sarah unloaded Company’s shares for reported $0.45 million
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Agios Pharmaceuticals
Agios Pharmaceuticals Inc’s filing revealed that its Chief Medical Officer Gheuens Sarah unloaded Company’s shares for reported $0.14 million on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Agios Pharmaceuticals